InsiderTrades

Form 4 for LIN Linde plc

Accepted 2022-05-27 00:00:00 ET · period of report 2022-05-25 · accession 0001062993-22-013650 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-05-27 2022-05-25 LIN Lamba Sanjiv CEO, Dir M - OptEx $1.92 +2,840 47.1K +6% +$5,453
D 2022-05-27 2022-05-25 LIN Lamba Sanjiv CEO, Dir M - OptEx $0.00 -2,840 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Ordinary Shares 2022-05-25 M A 2,840 $1.92 47,084 D — — (F1) There was no market sale of shares, and the reporting person held the total 2,840 shares resulting from the stock option exercise.
2 Derivative Stock Option (right to buy) 2022-05-25 M D 2,840 $0.00 0 D $1.92 · 2021-06-07 to 2022-06-07 2,840 Ordinary Shares (F9) Stock options have been granted pursuant to the Business Combination Agreement among Praxair, Inc., Linde AG, Linde plc and certain of their affiliates, dated June 1, 2017, as amended (the "BCA"). The stock options replace certain previously granted equity awards granted by Linde AG that were terminated in connection with the closing of the Business Combination of Praxair, Inc. and Linde AG that occurred on October 31, 2018. A more detailed explanation of these stock option replacement awards is discussed in the Linde plc Registration Statement on Form S-4 (Amendment No. 4) filed with the SEC on August 11, 2017 under the section titled "The Business Combination - Interests of Directors, Board Members and Executive Officers in the Business Combination - Linde AG - Treatment of Equity Awards" on pages 183-187.